This brief history of the use of extracts of Colchicum autumnale in the treatment of gout had its origin in some research relative to the metabolism and mode of action of colchicine. It was interesting to review this history in order to develop a background, and thus to learn what ancient authorities and later observers knew about this drug. We shall review the evidence for the identity of certain plants thought by many investigators to be identical with our modern Colchicum autumnale, and which were described by early writers as poisons and later recommended in the treatment of gout; re-emphasize knowledge which has been more or less forgotten but which could be of experimental and practical usefulness to-day; delineate the fluctuations of popularity of colchicum as a treatment for gout during the past 1,500 years; and briefly mention the history of its uses in other fields of research. At the present time colchicine and its derivatives, as well as other mitotic-arresting drugs, are of considerable importance in the field of cancer research. More thoroughly established, however, is the role of colchicine in the treatment of acute attacks of gout, and it is this latter role that concerns us most here.
This brief history of the use of extracts of Colchicum autumnale in the treatment of gout had its origin in some research relative to the metabolism and mode of action of colchicine. It was interesting to review this history in order to develop a background, and thus to learn what ancient authorities and later observers knew about this drug. We shall review the evidence for the identity of certain plants thought by many investigators to be identical with our modern Colchicum autumnale, and which were described by early writers as poisons and later recommended in the treatment of gout; re-emphasize knowledge which has been more or less forgotten but which could be of experimental and practical usefulness to-day; delineate the fluctuations of popularity of colchicum as a treatment for gout during the past 1,500 years; and briefly mention the history of its uses in other fields of research. At the present time colchicine and its derivatives, as well as other mitotic-arresting drugs, are of considerable importance in the field of cancer research. More thoroughly established, however, is the role of colchicine in the treatment of acute attacks of gout, and it is this latter role that concerns us most here.
In the preparation of this study we have received invaluable assistance from Professor William H.
Stahl, Chairman of the Department of Classics of
New York University, who translated some of the Greek and Latin of the original manuscripts; and from the Inaugural Dissertation of Doctor Kurt Ruegg of Basel (Ruegg, 1936) , on which we have relied heavily for our discussion of the mediaeval period. A resume by Sharp (1909) has also been of some help, as has the work of Schnitker (1936) .
The Drug Colchicine To-day, in the treatment of acute attacks of gout, colchicum is administered as the relatively pure colchicine. The original structural formula elucidated by Windaus (1924) has been shown to be incorrect. The formula proposed by Dewar (1945) , where colchicine contains a tropolone ring system is now accepted and has received experimental justification (Arnstein and others, 1948, 1949; Cech and gantavy, 1949;  Doering and Knox, 1951 ).
The drug is given by mouth in tablet form, 0 01 gr. each, at the onset of a gouty attack, and then every hour for five to ten doses until diarrhoea is induced. Usually at the onset of the diarrhoea the acute joint begins to resolve. In chronic gout some advocate its use in doses of 0 01 gr. once or twice a day over a prolonged period of time. Intravenous colchicine also has its advocates. Tinctures and wines of colchicum are to-day considered less desirable because of the possible variability in their drug content. The new hormones cortisone and ACTH have by no means usurped the ancient and useful position of this drug.
The mode of action of colchicine in gout is still a mystery. The most important known effect of colchicine, which is to inhibit the completion of mitosis or the division of cells, holding the process in what is called the metaphase, may or may not be related to the favourable effect of colchicine in an acute attack of gout. Proper spindle fibres necessary to normal cell division fail to develop. The chromosomes may divide in spite of the failure of cell division, thus giving rise to polyploidy or multiple sets of chromosomes. In larger doses not only do the dividing nucleii fail to produce the spindle but the chromatic material becomes pyknotic and degeneration of the cell proceeds.
The effect on mitosis is induced by 0 001 of the amount necessary to produce other observable metabolic effects on the cell, and its remarkably selective action is shown by the fact that the nuclear effects of other compounds are far less marked. To induce comparable effects with sodium cacodylate for example, one must use dosages a million times as great.
Anton Stoerck and others recognized a diuretic effect, and this has recently been investigated by COLCHICUM IN GOUT Dicker (1951) . Hormone (Havas, 1938) , enzyme, shock-like effects (Selye, 1949) , and a reduction of vitamin C content of tissues, have all been postulated. Colchicine is moderately bacteriostatic (Gohar and Makkawi, 1951) . It apparently has no effect on uric acid excretion. Its effect or lack of effect on uric acid metabolism awaits elucidation.
The unique poisonous effects of colchicine, of importance in this historical study, have been known since ancient times. There appear to be two distinct actions. First are the immediate irritating effects on gastro-intestinal tract, possibly by exciting the nerve endings to smooth muscle (Jacobj, 1890) , but more likely through a central effect (Ferguson, 1952) . Its action in this regard can be compared to that of muscarine, pilocarpine, and physostigmine. Secondly, colchicine, even in relatively enormous doses, produces a lethal effect slowly, requiring 3 to 6 hours to cause death in carnivore and longer in herbivore. This delay may be due, as in bacterial toxins, to a delay in absorption into the central nervous system (Dixon and Maiden, 1908; Dixon, 1915) or, as Brues suggests (personal communication), to the possibility that the lethal action is associated with a metabolic factor such as the disappearance or accumulation of a critical metabolite. Death is apparently caused by vasomotor and respiratory paralysis. Hamsters do not succumb to colchicine poisoning (Orsini and Pansky, 1952) .
Toxicity studies on poikilotherms, in whom the body temperature closely parallels the environment, show that these cold-blooded animals have remarkable tolerance to colchicine (Fuhrman, 1946) , frogs requiring a dose of 100 mg. to I gram to prove fatal. However, the frog may be rendered much more sensitive by placing it in an incubator for a few days before the administration of the drug. Such preheated animals die with doses of 0-1 to I mg., but only after a delay of 2 to 5 days. The toxicity of colchicine in frogs was increased 400 to 500 times when the temperature was raised from 20°to 320 C. (Fuhner, 1913; Sanno, 1911) .
The present-day supply of colchicine in the United States is derived mainly from botanical drug concerns who import the seeds and corms of the plant Colchicum autumnal from the temperate regions of Europe and from North Africa. This is due to economic factors, as our native corms should be just as productive. This material, received in a dry state, is treated with various solvents, more or less following the methods of extraction, purification, identification, and assay described in the U.S. Pharmacopeia. Further purification by chromatography can be accomplished by the method of Ashley and Harris (1944) . Colchicine U.S.P. is said to contain 4 per cent. desmethyl-colchicine (Horowitz and Ullyot, 1952 
ANNALS OF THE RHEUMATIC DISEASES
Colchicine is present in all parts of the plant, but particularly in the corm (0135 per cent.), seeds (0 45 per cent.), and flowers (O.80-0 81* per cent.). The seeds are collected in June and July and the corms in July and August, or during flowering time, when they are considered to be the most rich in colchicine, although there is scant experimental evidence for this. Other plants known to contain colchicine are Androcymbium gramineum (Perrot, 1936) , Gloriosa superba and species of Merendera (Mehra and Khoshoo, 1951) , and Gloriosa Rothchildiana (Bryan and Lauter, 1951) .
Colchicum autumnale may be confused with members of the Crocus family, particularly the Autumn Crocus, but it can be easily distinguished from them by the fact that the crocuses are of the Iris family, having three stamens, whereas the colchicums have six. Colchicum autumnale is only one of many colchicums. There are some thirty species of the genus (Krythe and Wellensiek, 1942) , including a few spring-flowering varieties, all of which produce colchicine.
To use the terms Meadow Saffron or Saffron Crocus as synonymous with colchicum is confusing in that these terms suggest the Crocus sativus, a plant well known to the ancients, and described by Dioscorides, which has been throughout the ages the source of saffron, a medicinal drug, a perfume, a flavour, and a brilliant yellow dye. Crocus sativus is of the Iris family and has no relationship to the colchicums. It is still considerably cultivated in Spain and to some extent in America and England, but the large industry at Saffron Walden in England is a thing of the past (Bowles, 1924 Bolbos. The Romans call it Bulbus agrestis. As the autumn is drawing to a close, the plant puts forth a whitish flower, like the flower of the Crocus. Later it bears leaves somewhat like those of the Bulbus, but shinier. It has a stalk a span long and reddish seeds; its root has a tawny skin verging into black. When peeled, the root is found to be white, tender, full of juice, and sweet. The plant has its diaphysis at about its middle, from which point it sends forth its flower. The plant is found chiefly in Messenia and Colchis. When eaten, it has a fatal effect by choking, as is the case with mushrooms. We have described the plant so that no one may confuse it with the edible Bulbus and eat it by mistake. It has a strange attraction for the unwary because of its pleasant taste. In the English translation of Dioscorides (Goodyer, 1655; ed. Gunther, 1934) , the terms are reversed, and the chapter on the poisonous variety begins "Colchicum, which some call Ephemeron". Gunther does not state the name of the Codex translated by Goodyer, but the illustrations are obviously taken from the "Julianae Aniciae Codex".
It is clear from the above that writers of the Dioscorides codices considered that there were two kinds of group.bmj.com on July 8, 2017 -Published by http://ard.bmj.com/ Downloaded from meron, one "which some call Colchicon", probably the present-day colchicum, and another totally different, non-poisonous plant, apparently an Iris, recommended for toothache and tumourous swellings.
The section in the "Julianae Aniciae Codex" dealing with the "Ephemeron, which some call Colchicon", and that in the "Cheltenham Codex", are each accompanied by an illustration (Figs 2 and 3 ). These are fairly accurate representations of colchicum, but the plant is shown with leaves and flowers together, a phenomenon which does not occur with Colchicum autumnale or with the Colchicum variegatum of the Middle East. It may be a springflowering variety or the artist may have wanted to depict the various stages of the plant's growth in one diagram.
Scribonius Largus (c. A.D. 14-54) copied Nicander, adding nothing to the subject. Pliny the elder (A.D. 23-79) in his "Natural History", described the ephemeron, referring to it as the Iris agrestis of Dioscorides, and did not mention the poisonous ephemeron or colchicum. Colchicum, but the other which is called Iris agria", and does not discuss colchicum itself either as a poison or as a drug. Aretaeus (2nd cent. A.D.), who wrote a most penetrating description of gout, says that "in gouty cases Hellebore is the great remedy". The leaves of hellebore or veratrum can be confused with those of colchicum. Aretaeus recommends the iris also, but does not mention either colchicum or ephemeron. Oribasius (4th cent. A.D.) copies Galen; he discusses the nonpoisonous ephemeron, "not the poison which some call Colchicum". Up to this point, then, it would appear that the ancients knew of a plant which they called "Ephemeron or Colchicum". It was poisonous and similar in its appearance and effects to the modern colchicum, and had for them no useful place in medicine. Another plant, also sometimes called ephemeron but never colchicum, is described as non-poisonous; it is sometimes called the Iris agrestis (Wild Iris), and was used in medicine for toothache and tumours.
Hermodactyl.-Alexander of Tralles (c. A.D. 550), in his "Therapeutica" made no mention of either ephemeron or colchicum. In his masterly discussion of gout, he recommended hermodactyl (Hermes for Mercury and dactylus, a finger) as a drug of choice. He gave no botanical description and its real identity is still a matter of dispute. He applied hermodactyl as we should colchicum to-day, giving it for gout, primarily for acute 
attacks. The patients "declare that they get rid of their pain immediately because this medicine eliminates the toxic material with the stool movements, and the sick person can walk". He noted its cathartic effect, particularly warning against its irritating action on the stomach and intestines, and gave many prescriptions containing hermodactyl, preferably in pill form, with carminatives and cathartics added "in order to counteract the untoward effects on the gastro-intestinal tract". The evidence in favour of identifying hermodactyl with colchicum is first that the indications and effects appear similar, and second that Alexander does not once mention colchicum or ephemeron, a notable fact in that he was naturally familiar with the "Herbal" of Dioscorides.
Paul of Aegina (7th cent. A.D.), in his "Epitome", mentioned all the terms so far discussed: Ephemeron, "which some call Colchicum (because it grows in Colchis) or Bulbus silvestris", which is designated as a poison as in Nicander and Dioscorides; and again Ephemeron, "not the poisonous species but that which is called Wild Iris"; and lastly Hermodactyl, saying that "the root of it is possessed of purgative properties", and it is good "for affections of the joints in rheumatism", and bad for the stomach.
Paul of Aegina made a clear differentiation between the three terms so far discussed. In addition, he mentioned "recourse to preparations of Saffron", as distinct from the above three. We cannot be sure, however, whether Paul knew for a fact that all three were different, or whether he was merely copying from the texts of Dioscorides, Alexander, or others, without any personal knowledge of the subject. He himself admitted that he was not an original writer, but merely an eclectic.
References to colchicum and related terms in the Western world during the Middle Ages appear to be few. For example, Gilbertus Anglicus (1170-80? to 1230) refers to formulae called "Pilulae Artheticae Salernitorum", "Pilulae Arabice", etc., the active ingredient of which was a root he called hermodactyl.
Surugen.-The Arabic writers introduced a new term, "Surugen", with many variations of spelling. John Mesue (928-1018) , in his "De re medicina libri tres" (Ruegg, 1936) , spoke of "the Hermodactyl or Surugen", making the two synonymous. Mesue recommended it particularly for diseases of the joints and was the first to mention that the corm must be dried for 6 months before being used, fresh corms being "extremely poisonous".
Abu Mansur (10th cent. A.D.) spoke of "Surindschan" (Riiegg, 1936) . Avicenna (980-1037) referred to "Hermodactyl or Surengian" and stated that it was a root with white or yellow flowers, was good for podagra, and, as recommended by Alexander of Tralles, was best given with carminatives and cathartics.
Other Arabic writers are mentioned by Ruegg (1936) ; Ibn-El-Beithar (1197-1248), for example, considered Hermodactyl and Surugen to be identical, but Serapion Junior (11th cent. A.D.) is most notable for our purpose because he made all the terms synonymous. Serapion said that "Surugen is Hermodactyl" and that "Hermodactyl, which is also called Achimeron" is similar to the Saffron, has leaves like the onion, a stem one span long, and a white root with a red cover, the root being soft, sweet, and toxic as mushrooms. He recommended cow's milk as an antidote (as did Dioscorides), and stated that it was used as a treatment for arthritis. Serapion, then, in making completely synonymous all the three terms so far discussed, is exactly contrary to Paul of Aegina. As far as we can determine he was the first to state (although it may have been common knowledge) that ephemeron or achimeron had a place as a medicine and not as a poison only, that it was valuable in the treatment of arthritis, and that it was synonymous with hermodactyl and surugen. His words were apparently unchallenged for the next 500 years, when he was attacked on this point, particularly by Euricius Cordus (see below).
At the same time hermodactyl, and not surugen, was still the term of choice in the Byzantine Empire. In a treatise on gout written for the Emperor Michael Palaeologus (c. 1282 A.D.) by Demetrius Pepagomenus, are prescriptions for hermodactyl pills, mixed with cathartics such as aloes and carminatives such as licorice or cinnamon, to render them "agreeable to the stomach".
Herbstzeitlose and Colchicum Autumnale. By the time of the Renaissance a new term had appeared in Central Europe-"Herbstzeitlose", variously spelled and possibly meaning "without time" or "out of season", though many other derivations have been offered. It is a term which undoubtedly arose in the vernacular and was then gradually incorporated into the herbals. Botanical and medical writers soon began to use it as synonymous with the other terms discussed above.
Hieronymus Brunschwig (1450 Brunschwig ( -1539 , an Alsatian army surgeon, in his "Distillierbuch", for example, said that "wild saffron is the corm of Hermodactyl or Zeitlose". He followed Mesue in stressing the fact that it is dangerous if not dried long enough. The "Hortus Sanitatis" (Ruegg, 1936) , a herbal with many wood-cuts, published in Mainz in 1485, made the problem appear quite simple by stating that the zeitlose was the hermodactyl of the Latins, the achimeron or colinticon of the Greeks, and the sturagen or Surumen of the Arabs, and that it was good for gout and dropsy and might be used externally with benefit in a number of conditions. Other authors, including Otto Brunfels (1488-1534), one of the fathers of botany, who wrote an "Herbarium or Lexicon of Medical Simples", also stated that these terms were synonymous.
A contrary opinion, however, may be seen in the writings of Euricius Cordus (1486-1535), a physician and botanist, who pointed out that Paul of Aegina put hermodactyl in a separate category from ephemeron and colchicum. Cordus thought that Serapion and many subsequent writers had erred in saying that these were synonymous terms.
Other early herbalists and botanists, and particularly students and translators of Dioscorides, attempted to identify these ancient terms (Ruegg, 1936 Thus we see that the Arabs apparently accepted the opinion that the terms were synonymous, while during the early mediaeval period the Western world seemed silent on the subject. From the 15th century, however, the argument raged vigorously as to the identity of these terms. Unless new evidence is uncovered it seems doubtful whether the controversy will ever be settled. It is the author's opinion that the circumstantial evidence is in favour of the terms being identical.
The works of Alexander of Tralles (6th cent. A.D.) contain the first record of the use of colchicum in gout, assuming colchicum and hermodactyl to be identical. As hermodactyl, the drug, was used in gout in the Byzantine world, and as surugen it was used by the Arabic physicians. As hermodactyl it appeared in the earliest English literature, and as herbstzeitlose in that of Central Europe. (Hammond, 1861) . Dicker (1951) "We are informed by himself that in the course of researches to which his propensity led him, he discovered a plant before unknown in medicine, which upon examination, was found to possess extraordinary virtues in the cure of various diseases."
Administration in Gout
From the beginning the concoction met with much opposition:
"The clamours against it became at length so loud, that the sale of it was suppressed in Paris, in 1778, by an order from the police. This prohibition was removed on the fifth day." Want (1814), after considerable experimentation and observation, stated that the main ingredient of "Eau Medicinale" was a venous infusion of colchicum corm; he called the attention of the medical profession to the influence of colchicum itself in the treatment of gout. Want was followed by other authors, such as Clark (1818) . Sir Henry Halford (1831), thought highly of colchicum in gout, and, like Mattioli before him, sent to Constantinople for specimens of hermodactyl, and proved to his own satisfaction that they were identical with Coichicum autumnal. Home (1817), brother-in-law of John Hunter, and the man who, according to Garrison, burned Hunter's manuscripts and then used the material as his own original work, had gout himself, experimented with "Eau Medicinale" and colchicum and stated that colchicum was a "specific" remedy for gout and was the main ingredient of Husson's formula. To this Scudamore (1819) , in his "Treatise on the Nature and Cure of Gout and Rheumatism" and other writings, somewhat reluctantly agreed, and from that time on the study and use of colchicum belongs to contemporary history.
The reintroduction of colchicum was attended by over-enthusiasm; thus, Haden (1820) and Maclagan (1852) gave a long list of asserted indications. The latter gives an extremely interesting and impartial survey on the subject, equal to his penetrating remarks on rheumatic fever. Moderation was again restored by the publication "The Nature and Treatment of Gout and Rheumatic Gout" (Garrod, 1859) . Almost all our pertinent knowledge of colchicum is to be found in Garrod's classical descriptions. The only important aspect not known to Garrod was the drug's effect on mitosis. Garrod, like the ancients, recommended that a cathartic such as calomel be administered with colchicum.
Since Garrod's time very little of a positive nature has been added to our knowledge of the use and mechanism of action of colchicine in acute gout. Garrod (1848) had shown and verified that there was an increased amount of urates in the blood of gouty subjects, but that colchicum did not affect the blood level or excretion of urates. Theoretical explanations of its action (as an enzyme, as a hormone, as a "shock drug" acting through the pituitary-adrenal axis, or as inhibitor of uric acid synthesis) have been repeatedly proposed but without good experimental evidence. The attractive hypothesis that the mechanism of action in gout is in some way related to the phenomenon of mitotic arrest induced by colchicum is also without any support whatever.
Colchicum had been isolated by Pelletier and Caventou (1820). Geiger (1833) had extracted a fairly pure colchicum and called it colchicine. Zeisel (1883) elucidated the chemistry still further and worked out its empirical formula (C22H2506N). Houdes (1881, 1884) accomplished further purification. Jacobj (1890) wrote extensively of its properties. Santavy and Reichstein (1950) have isolated four other colchicine-like substances from the seeds of the plant, but their properties are as yet unknown.
The history of the effect of colchicum and some 47 other chemicals (Krythe and Wellensiek, 1942) in inducing mitotic arrest has profound significance in cancer research, as well as in many other fields, such as endocrinology, genetics, and cytology, but this work is not within the scope of this summary.
Of the 47 (which include acriflavine, podophyllotoxin, and auramine), colchicine is unique in that, as mentioned above, it acts in dosages far below the levels that would interfere with general cell metabolism. In suitable doses it inhibits only the metaphase. The literature on this subject is extensive indeed, the bibliography of Eigsti (1947) taking up 48 pages. Dustin and Gregoire (1933a, b) observed the effect of arsenical and other compounds on nuclear division in grafted mouse tumours. Lits (1934) , working in Dustin's laboratory at the University of Brussels, reported on the general cellular reactions and "lesions" caused by colchicine in animal cells. Amoroso (1935) observed the beneficial effect of colchicine on the malignant growths of patients treated primarily to relieve acute attacks of gout and tested the efficacy of colchicine on malignant tumours in animals. Ludford (1936) reported on its action on normal and malignant cells in vitro and in vivo. He is credited with having pointed out that the inhibitory action of colchicine on mitosis is not at the onset, but in the metaphase. Any one microscopic slide will show an increased number of cells in mitosis, but this apparent stimulative effect, as first suggested by Dustin and his co-workers, was shown by Ludford to be merely an accumulation of the arrested cells. Ludford showed at an early date that the effective dose was unfortunately at or only just below the lethal dose. Havas (1937) and Gavaudan (1937) were the first to show the effect of colchicine on the germination of wheat seeds and the growth of seedlings, and the extent to which a parallelism can be found in this regard between animal and plant cells. Brues (1936) , Brues and Marble (1937) , Brues and Cohen (1936) , and Brues and others (1940) , investigated the effects of colchicine on the regenerating liver of the rat following partial hepatectomy, and used this observation to develop a method of measuring the anti-mitotic action of any particular drug. Allen and others (1936) , working at the Yale Medical School, introduced these effects to endocrinologists, pointing out the application of the colchicine effect to hormone study and assay. The investigations in America culminated in the successful demonstration of polyploidy (chromosomal division without cell division) in plants by Blakeslee (1937) , Blakeslee and Avery (1937), Nebel (1937) , Nebel and Ruttle (1938) , Eigsti (1947) , and many others, and suggested the possibility of developing new species through the application of a drug like colchicine. The subsequent literature of colchicine and related compounds while voluminous (Eigsti, 1947) mainly centres in problems in other fields than that of gout.
The most recent significant advance in our knowledge of colchicum was the production of radioactive colchicine, randomly labelled with carbon C-14 by the biosynthetic procedures developed by Geiling, Kelsey, McIntosh, and Ganz (1948) . This radioactive preparation was used by Back and others (1951) at the same laboratory to trace the fate of colchicine in vivo.
Suggestions for Future Investigations A summary of useful suggestions that may be gleaned from this brief history appears to be worthwhile. It might be fruitful to investigate the effect of the other ingredients of colchicum corm, continuing the work of gantavy and Reichstein (1950) ; the content of the corm at various times of the year; the content and type of drug present in fresh corms and in corms "dried over 6 months"; the effect of colchicum as a diuretic; a clinical trial of the conjoined use of carminatives and cathartics with colchicine, as was the custom with the ancients, rather than the administration of paregoric to allay the final diarrhoea as is at times the practice to-day; a re-investigation of the use in gout of hellebore (veratrum) which appears now to have a synergistic effect with colchicum; the application of colchicine locally for its effect on tumours (Nelson, 1951) and ulcers, and for its possible systemic effect in arthritis when locally applied (Carr, 1951) ; and the possibility of poisoning through prolonged administration in chronic gout. The metabolism and the mode of action of colchicine in gout is an open field for research.
Many references to the history of colchicum in current medical literature are erroneous and these errors have been carried over from article to article. We hope we have corrected some of these without adding others of our own.
Summary
The use of colchicum first as a poison and later in the treatment of gout can be traced back at least 2,000 years. The new hormones, cortisone and ACTH have by no means usurped the ancient and useful position of this drug.
The most important known effect of colchicum which is to inhibit completion of mitosis or the division of cells, may or may not be related to its favourable effect on an acute attack of gout. Other theories as to its mode of action in gout have been proposed, but without sufficient evidence to establish their validity.
The toxicology of colchicum is unique in that it produces its lethal effects slowly, requiring a number ANNALS OF THE RHEUMATIC DISEASES obtained, is a perennial plant of the Lily family, and must not be confused with the Crocuses, which are of the Iris family and contain no colchicum.
It is probable that colchicum was known to the early Greeks under the term Ephemeron "which some call Colchicon". It was first referred to, and as a poison, by Theophrastus, and subsequently by Dioscorides, from whose "Herbal" two pictures of Ephemeron are reproduced in this text.
Alexander of Tralles (c. A.D. 550) in his "Therapeutica", made no mention of either ephemeron or colchicum, but recommended hermodactyl as the drug of choice. He gave no botanical description and the real identity of hermodactyl is in dispute. The reasons in favour of identifying hermodactyl with colchicumare first that theindications and effects appear similar, and second that Alexander does not once mention colchicum or ephemeron, a notable fact in that he was naturally familiar with the "Herbal" of Dioscorides.
The Arabic physicians introduced a new term, surugen, and later made all three terms synonymous. Serapion said that "Surugen is Hermodactyl" and that "Hermodactyl is also called Achimeron". The Arabs recommended this Surugen for the treatment of arthritis.
Meanwhile, in Central Europe, probably during the late Middle Ages, a new term-herbstzeitlosedeveloped, and this was recommended for the treatment of gout. The controversy as to the identification of herbzeitlose with ephemeron, colchicum, and surugen, which immediately arose lasted until the 19th century. The bulk of evidence appears to support the thesis that these terms are synonymous.
The use of these plants in gout underwent great fluctuations in popularity. As hermodactyl the drug was used in gout by the Byzantines, and as surugen it was used by the Arabs. As Historia del empleo del c6lchico y de medicamentos aliados en la gota con sugestiones para investigaciones ulteriores SUMARIO El uso del c6lchico-como veneno y luego en el tratamiento de la gota-se conoce desde al menos 2.000 afnos. Las nuevas hormonas, como la cortisona o la ACTH, no usurparon de manera alguna la posici6n antigua y util de este medicamento.
El mAs importante efecto del c6lchico que se conozca, el de inhibirla fase terminal dela mitosis o de la division celular, estaria quizas en relaci6n con su efecto favorable en el ataque agudo de la gota. Fueron emitidas otras teorias sobre el modo de accion del c6lchico sobre la gota, pero sin pruebas suficientes de validez.
La toxicologia del c6lchico es uinica en que su efecto mortal es lento, ejerciendose tan s6lo despues de algunas horas en los carnivores y todavia mas tarde en los herbivores. Algunos animales poiquilotermos no sufren practicamente sus efectos t6xicos a menos de calentarlos.
Colchicum autumnal del cual viene el medicamento, es una planta vivaz de la familia liliacea, que no se debe confundir con el azafran que es un iridaceo.
Es probable que los griegos antiguos conocieron el c6lchico con el nombre de ephemeron "que algunos llaman Colchicon". Primero a mencionarle, como veneno, fue Teofrasto; le sigui6 Dioscorides, de cuyo "Herbal" se reproducen aqui las dos figuras de ephemeron.
Alejandro Traliano (550 A.C.) en su "Therapeutica" no hace menci6n de ephemeron ni de c6lchico pero recomenda hermodactyl como medicamento de elecci6n.
Faltando la descripci6n botanica, su identidad es opinable, pero existen dos razones en favor de la tesis que hermodactyl y c6lchico son identicos: las indicaciones y los efectos parecen similares y, ademas, Alejandro nunca menciona el c6lchico o el ephemeron, hecho notable ya que naturalmente conocia el "Herbal" de Dioscorides. Los medicos arabes introdujeron un termino nuevo, surugen, haciendo sin6nimos los tres terminos. Serapion dijo que "surugen es hermodactyl" y que "hermodactyl se llama tambien Achimeron". Los arabes recomendaron surugen para artritis. Entretanto en Europa Central, probablemente hacia los fines de la edad media, nacio un termino nuevoHerbstzeitlose, recomendado contra la gota. Una polemica respecto a la identidad de Herbstzeitlose, ephemeron, surugen y c6lchico empezo muy pronto, prolongAndose hasta el XIX siglo. La mayoria de las pruebas parece soportar la teoria de su identidad.
La boga de esta planta contra la gota sufri6 grandes fluctuaciones. Como hermodactyl la emplearon los bizantinos y como surugen los Arabes. La antigua literature medica inglesa menciona hermodactyl y la de la Europa Central Herbstzeitlose. En el siglo XV, sin embargo, su empleo contra la gota sufri6 descredito a causa de manifestaciones t6xicas secundarias que los medicos tuvieron dificuldad en controlar. En consecuencia, casi todos los medicos del XVII y del XVIII siglo ignoraron el c6lchico en el tratamiento de la gota.
La historia moderna del empleo del c6lchico contra la gota empieza con Nicolas Husson, que no era medico sino oficial del ejercito francs, quien confeccion6 una panacea, Eau Medicinale; se supo mds tarde que su ingredients activo principal fue c6lchico. Esta planta ocup6 el primer lugar en el tratamiento del ataque de gota con los escritos de Scudamore (1819), soportado por Garrod mayor. Desde los tiempos deeste poco fue afiadido a nuestros conocimientos de posologia y del modo de acci6n del c6lchico.
El efecto del c6lchico de parar la mitosis fue aplicado experimentalmente en la investigation de los tumores, empezando con Dustin y sus colaboradores en 1933.
Esta obra tuvo gran importancia en la investigaci6n del cancer asi como en muchos otros dominios, como endocrinologia, genetica y citologia.
El estudio de la historia del c6lchico pone de relieve problemas que quedan por solver respecto al aislamiento, posologia y farmacodinamia. Asimismo, el metabolismo y el modo de acci6n del c6lchico en la gota abren un campo de investigaci6n.
